Enzo Biochem Operating Income

Enzo Biochem (ENZ) currently reports a operating income of $-11M as of April 2025. That compares with $5.6M in the prior-year period — down 293.3% year over year. Use the charts on this page to explore Enzo Biochem's operating income history and peer comparisons.

Enzo Biochem's operating income decreased from $5.6M to $-11M — a 293.3% year-over-year decrease (period ending April 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enzo Biochem reported $-11M in operating income as of April 2025. That compares with $5.6M in the prior-year period — down 293.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enzo Biochem, and consider following ENZ for alerts when major investors trade the stock.

Enzo Biochem is classified in the Healthcare sector. On operating income, it currently shows $-11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ENZ with unrelated industries.